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Exploring the Pathophysiological Concepts of Ebola Virus
Andrew T. Wasson, BSN, RN
Otterbein University, Westerville, Ohio

Introduction
The increase and ease of globalization
along with emerging infectious diseases
puts populations at a higher risk for
contracting infections capable of causing
severe morbidity and mortality. Viral
infections are a common source of illness
worldwide, and the severity of illness can
depend on many factors such as the type
of virus, the host’s natural defense, and
the availability of resources and
treatments. Ebola has been a hot topic in
the news lately as a result of the recent
2014 outbreak in West Africa that
eventually found its way into the United
States. According to Bray and Chertow
(2015) “As of June 28, 2015, the
cumulative number of probable,
suspected, and laboratory-confirmed
cases attributed to Ebola virus is 27,550,
including 11,235 deaths.” Ebola was first
discovered in 1976 near the Ebola River
within the Congo region of Africa (CDC,
2015). The Ebola virus is a member of the
filoviridae family. Five different species
have been identified, four of which are
known to cause disease in humans (CDC,
2015). The Ebola virus has historically
been termed Ebola hemorrhagic fever,
however this term is no longer widely
accepted due to fact that only about 1/3
of patients who contract Ebola develop
hemorrhaging (Rougeron, Feldmann,
Grard, Becker & Leroy, 2014). Rapid action
and containment along with a touch of
luck prevented a possible epidemic in the
United States, but does not mean we are
immune to another potential threat in the
future. Additionally, our country has been
in a war for well over a decade with
seemingly no end in sight. The aftermath
of September 11th, 2001 lingers on, and
the reality of continued terrorism remains
a fear for the majority of Americans. We
have come to understand that many of
these terrorists who plan to do harm to
our nation live in our communities. This
reality makes the threat of terrorism even
more frightening, and bioterrorism is no
exception. While the debate remains, the
recent outbreak of Ebola has many
bioterrorism experts concerned over the
possibility of ‘weaponizing’ the highly
infectious agent, which would
undoubtedly wreak havoc on our nation.
While the news has seemed to steer away
from talking about Ebola, we must not let
our guard down. As health care
professionals, we should familiarize
ourselves with pathophysiologic concepts
regarding Ebola should an epidemic occur.

Pathophysiological Processes
The Ebola virus is a member of the
filoviridae family. Five distinctive species
of ebolavirus have been identified, four of
which are known to cause disease in
humans (Martines, Ng, Greer, Rollin, and
Zaki, 2014). The specific species known to
cause disease in humans are Zaire, Sudan,
Ivory Coast, and Bundibugyo (Bray &
Chertow, 2014). Bah et al. (2015) report
that the Zaire ebolavirus (EBOV) was the
cause of the most recent West African
outbreak and carries the highest human
mortality rate among the five known
species, with up to 90% of cases being
fatal. Ebola is a filamentous, enveloped,
single-stranded, negative-sense RNA virus
(Martines, et al., 2014). According to
Jarrett (2014), just ten Ebola microbes are
needed to successfully transmit the virus
from human to human, proving it to be
highly capable of infectivity. “Outbreaks
typically originate with introduction of
the virus into humans from a wild animal
reservoir, with subsequent human-tohuman transmission, often fueled by
nosocomial amplification in resourcepoor settings” (Bah, et al., 2015, p. 40).
Ebola can be spread by direct contact
with various infected animal species
including primates and bats, however the
virus is not spread via the airborne route
(CDC, 2014). Fruit bats are considered to
be reservoirs of Ebola virus. After the
initial transmission from animal to
human, Ebola spreads “via direct contact
(through broken skin or mucous
membranes) with the blood, secretions,
organs or other bodily fluids of infected
people, and with surfaces and materials
contaminated with these fluids” (Nault,
2014).

Once the virus enters the body, it can
quickly invade and affect nearly all cell
types including epithelial cells, dendritic
cells, monocytes, hepatocytes and
endothelial cells (Bray & Chertow, 2015).
Macrophages and monocytes are
thought to be the first cells to be
infected, causing the release of proinflammatory cytokines (Rougeron, et al.,
2014). While lymphocytes are not
directly infected, apoptosis of this cell
type is commonly seen with this disease
leading to a deficient adaptive immune
response (Feldmann & Geisbert, 2011).
The virus invades the host through
damaged skin or mucous membranes
and attaches to the host’s receptor cell
where it then penetrates the cell through
endocytosis, uncoats itself, and is then
transcribed into positive-strain mRNA
(Jarrett, 2014). The rapid replication of
the virus within the host’s receptor cell
leads to cellular necrosis with
subsequent release of a large number of
new viral particles into the surrounding
space (Bray & Chertow, 2015). “In cases
of severe infection, there is a massive
release of pro-inflammatory mediators
and vasoactive substances, which
promotes inflammation and coagulation
but renders the immune system unable
to effectively prevent systemic spread of
the virus.” In late stages of the disease,
infected macrophages release tissue
factor causing disseminated intravascular
coagulation (Rougeron, et al., 2014). The
multiplied virions now in the
extracellular fluid are then able to travel
to various organ systems including the
liver, spleen, kidneys, and bone marrow
where they are capable of causing endorgan damage and destruction ultimately
leading to shock and death.

Above: Colorized transmission electron micrograph (TEM)
representing an Ebola virus virion.
© CDC, 2014

Case Study

Clinical Manifestations

J.M is a 34-year-old E.R nurse who is employed at a large
metropolitan hospital in Columbus, Ohio. J.M cared for a middleaged man approximately one week ago who embarked on a mission
trip to West Africa educating the community on the prevention of
sexually transmitted infections (STI’s). This patient’s health rapidly
declined and he ultimately expired in the hospital for reasons that
are currently being investigated by the coroner. The patient was
placed under strict isolation, however he was not in isolation while
under the care of J.M. J.M now presents to the urgent care with
complaints of generalized weakness, fatigue, myalgia, abdominal
pain, diarrhea and vomiting that began approximately 3 days ago
and her symptoms have progressively worsened. She states that the
flu has been going around at work.

Ebola virus has an incubation period of
2 to 21 days, but generally causes sudden
symptoms an average of 6 to 12 days post
exposure (Bray & Chertow, 2015). Early
symptoms are nonspecific and include flulike symptoms such as fever, chills, and
general malaise (Martines, et al., 2015).
These early symptoms are often difficult to
distinguish between other viral infections
making it challenging to diagnose early. As
the disease progresses, gastrointestinal
symptoms such as anorexia, nausea,
vomiting, and diarrhea become apparent
along with the development of a rash,
cough, and jaundice (Feldmann & Gesibert,
2011). Patients can also experience an
altered level of consciousness and seizure
activity along with a diffuse erythematous
rash (Bray & Chertow, 2015). These
symptoms generally indicate that the virus
has affected multiple organ systems.
Hemorrhagic signs and symptoms are only
seen approximately one third of infected
patients, is often considered the fatal stage
of the disease course, and manifests as
mucous membrane bleeding, epistaxis, and
hematemesis (Rougeron, et al., 2014). “The
systemic virus spread and replication, the
general dysregulation of the host immune
response, the coagulation abnormalities,
the impairment of the vascular system, and
hypotension all together finally result in
shock and multiorgan failure” (Feldmann &
Geisbert, 2011, p. 853).

Above: Map of West Africa depicting the # of days since the last
confirmed case of Ebola virus as of July 12, 2015. © WHO, 2015
J.M was a previously healthy, well-developed individual with no
past medical or surgical history. J.M is a nonsmoker, drinks alcohol
only on occasion, and denies illicit drug use. Vitals signs are blood
pressure 98/52, heart rate 124 beats/minute, respiratory rate 34
breaths/minute, temperature 102.4° F, oxygen saturation 96% on
room air. Physical exam reveals J.M is alert, oriented x 3. She appears
to be in moderate distress. She is tachypneic and diaphoretic. Lungs
are clear to auscultation bilaterally, no use of accessory muscles. She
has a moist cough. Cardiovascular exam reveals RRR with no clicks,
rubs, or murmurs noted, no JVD, and she has no peripheral edema.
Bowel sounds are hyperactive. Abdomen is soft, nontender. No
organomegaly is detected. At the urgent care, rapid strep test was
negative. CBC and chem 7 is unremarkable. Portable chest x-ray
reveals no infiltrates or atelectasis. Due to the fact that she recently
cared for an individual who became critically ill shortly after returning
from an international trip, she is sent to the nearest emergency
department for further testing and care. J.M is immediately placed in
negative pressure isolation. A polymerase chain reaction (PCR) assay
is conducted at the hospital and is positive.

Nursing Implications
The medical community, including
nurses and advanced practice nurses are
frontline clinicians that need to be
properly educated to better understand
the pathogenesis of the Ebola virus. This
understanding leads to better care for
patients and can prevent further spread of
the disease should an outbreak occur.
With terror threats becoming increasingly
frequent, the nursing community must not
rule out Ebola as a potential disease agent
of warfare targeted at Americans.
Additionally, Ebola should be considered a
diagnosis in patients presenting with signs
of infection that have recently traveled
internationally or been exposed to
someone with the virus (Martines, et al.,
2015). Highly infectious diseases such as
Ebola require the highest level of clinical
preparedness to adequately triage and
prevent a possible pandemic. Working
closely with local, state, and federal
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Clearly, the Ebola virus is capable of
producing widespread morbidity and
mortality. While the recent outbreak of
Ebola virus that penetrated American
cities was terrifying and had the
capability of causing an epidemic, the
medical community and healthcare
organizations learned a great deal about
the disease. This newfound respect for
Ebola has sparked a desire for better
treatment options including the
development of a vaccine, leading to not
only better health for Americans, but also
better outcomes for those in poor and
underserved countries in Africa.
Moreover, with continued terror threats
against the United States, we should not
rule out the possibility of Ebola being
used as a biological weapon.
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